Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DDB1 | Q16531 | 4/20 | 0.38 |
| ▸ | CRBN | Q96SW2 | 4/20 | 0.38 |
| ▸ | DPP8 | Q6V1X1 | 1/20 | 0.35 |
| ▸ | DPP9 | Q86TI2 | 1/20 | 0.35 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.34 |
| ▸ | SCN9A | Q15858 | 4/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 2/20 | 0.32 |
| ▸ | DRD2 | P14416 | 1/20 | 0.32 |
| ▸ | RIPK3 | Q9Y572 | 1/20 | 0.32 |
| ▸ | KCNQ4 | P56696 | 1/20 | 0.32 |
| ▸ | KCNQ5 | Q9NR82 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL33527198 | 0.77 | KCNQ4 (0.36) | SSTR4KCNQ4KCNQ5AAK1 | |
| Hydrochloric Acid SCHEMBL33526311 | 0.76 | P2RX7 (0.33) | DDB1CRBNKMT2A | |
| SCHEMBL33525705 | 0.75 | AAK1 (0.41) | KCNQ4KCNQ5KMT2AAAK1 | |
| SCHEMBL33526231 | 0.74 | CTSS (0.36) | KCNQ4KCNQ5AAK1 | |
| SCHEMBL33526532 | 0.74 | KEAP1 (0.38) | KCNQ4KCNQ5AAK1 | |
| SCHEMBL33526779 | 0.69 | AAK1 (0.38) | RIPK3AAK1 | |
| SCHEMBL33526461 | 0.67 | TSHR (0.41) | ALDH1A1KMT2A | |
| SCHEMBL19491486 | 0.67 | NR1H2 (0.40) | AAK1 | |
| SCHEMBL33526061 | 0.67 | KCNQ4 (0.35) | ALDH1A1KCNQ4KCNQ5KMT2AAAK1 | |
| SCHEMBL292041 | 0.66 | MAPT (0.43) | SSTR4ALDH1A1DRD2KMT2AAAK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | LILLY CO ELI (US) | 2026-04-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260091048-A1 | GIP RECEPTOR AGONIST COMPOUNDS | GIPR, GLP1R, GPR119 | DDB1 4176/4885CRBN 1920/4885DPP8 286/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.